Hypofractionated radiotherapy for breast cancer acceleration of the START A treatment regime: intermediate tolerance and efficacy

PURPOSE: Prospective evaluation of accelerated hypofractionated radiotherapy (RT) in breast cancer patients treated with 41.6 Gy in 13 fractions plus boost delivered five times a week. PATIENTS AND METHODS: Between 03/2009 and 10/2012 98 consecutive patients aged >55 years presenting with breast...

Descripción completa

Detalles Bibliográficos
Autores principales: Janssen, Stefan, Glanzmann, Christoph, Lang, Stephanie, Verlaan, Sarah, Streller, Tino, Wisler, Doris, Linsenmeier, Claudia, Studer, Gabriela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112649/
https://www.ncbi.nlm.nih.gov/pubmed/25059887
http://dx.doi.org/10.1186/1748-717X-9-165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112649/
https://www.ncbi.nlm.nih.gov/pubmed/25059887
http://dx.doi.org/10.1186/1748-717X-9-165

Ejemplares similares